Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Prakriti Gaba

Prakriti Gaba MD

Cardiovascular Medicine Fellow, TIMI Study Group, Brigham and Women's Hospital & Harvard Medical School.

Prakriti Gaba, MD, is a senior cardiology fellow at the Brigham and Women’s Hospital/Harvard Medical School and a research fellow at the TIMI Study Group. She is also an MPH degree candidate at the Harvard School of Public Health. She is passionate about pursuing a clinical career in Interventional Cardiology, and her research interests involve investigating novel treatments for coronary artery disease, valvular heart disease as well as rethinking clinical trial design.


Prakriti Gaba, MD and Brian A. Bergmark, MD are members of the Thrombolysis in Myocardial Infarction Study Group, which has received grant support through Brigham and Women's Hospital (Boston, MA, USA) from Abbott, Amgen, Anthos Therapeutics, AstraZeneca, Bayer HealthCare Pharmaceuticals, Daiichi-Sankyo, Eisai, Intarcia, Ionis, MedImmune, Merck, Novartis, Pfizer, Quark Pharmaceuticals, Regeneron Pharmaceuticals, Roche, Siemens Healthcare Diagnostics, The Medicines Company, and Zora Biosciences.